Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.

@article{Schnland2006AllogeneicAS,
  title={Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.},
  author={Stefan O Sch{\"o}nland and Henk M. Lokhorst and Agn{\'e}s Buzyn and V{\'e}ronique Leblond and Ute Hegenbart and G. Bandini and Andrew Campbell and Enric Carreras and Augustin Ferrant and Leanthe Grommisch and P. Jacobs and Nicolaus Kr{\"o}ger and Giorgio La Nasa and Nigel H. Russell and Pierre Zach{\'e}e and Hartmut Goldschmidt and Simona Iacobelli and Dietger Niederwieser and G{\"o}sta Gahrton},
  journal={Blood},
  year={2006},
  volume={107 6},
  pages={2578-84}
}
Using the European Group for Blood and Marrow Transplantation (EBMT) registry, we retrospectively studied 19 patients with AL (amyloid light-chain) amyloidosis who underwent allogeneic (allo; n = 15) or syngeneic (syn; n = 4) hematopoietic stem cell transplantation (SCT) between 1991 and 2003. For allo-SCT, full-intensity conditioning was used in 7 patients and reduced-intensity conditioning (RIC) in 8 patients. Engraftment was durable in 12 of those 15 patients. The median follow-up time is 19… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 47 references

Reduced-intensity conditioning does not improve survival compared to standard conditioning for patients with myeloma [abstract

C Crawley, S Iacobelli, B Björkstrand
Bone Marrow Transplant • 2005

duced - intensity conditioning does not improve survival compared to standard conditioning for patients with myeloma [ abstract ]

M Mielcarek, PJ Martin, W Leisenring
Bone Marrow Transplant • 2005

Similar Papers

Loading similar papers…